Publicité
Publicité

MAIA

MAIA logo

MAIA Biotechnology, Inc.

1.62
USD
Sponsorisé
-0.04
-2.47%
09 janv., 15:59 UTC -5
Fermé
exchange

Après-marché

1.61

0.00
-0.25%

MAIA Rapports sur les bénéfices

Ratio de surprise positive

MAIA a dépassé 8 des 12 dernières estimations.

67%

Prochain rapport

Date du prochain rapport
19 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.13
Variation implicite de Q3 25 (Revenue/ EPS)
--
/
-51.85%
Variation implicite de Q4 24 (Revenue/ EPS)
--
/
+8.33%

MAIA Biotechnology, Inc. earnings per share and revenue

On 07 nov. 2025, MAIA reported earnings of -0.27 USD per share (EPS) for Q3 25, missing the estimate of -0.19 USD, resulting in a -39.32% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.68% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analystes forecast an EPS of -0.13 USD, with revenue projected to reach -- USD, implying an baisse of -51.85% EPS, and hausse of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, MAIA Biotechnology, Inc. reported EPS of -$0.27, missing estimates by -39.32%, and revenue of $0.00, 0% as expectations.
The stock price moved up 2.68%, changed from $1.12 before the earnings release to $1.15 the day after.
The next earning report is scheduled for 19 mars 2026.
Based on 3 analystes, MAIA Biotechnology, Inc. is expected to report EPS of -$0.13 and revenue of -- for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité